期刊文献+

新型冠状病毒肺炎患者的焦虑抑郁情绪和躯体症状 被引量:17

Investigation of the mental health of patients with COVID-19
原文传递
导出
摘要 目的评估新型冠状病毒肺炎(COVID-19)患者隔离治疗期间的心理健康状态及其影响因素。方法2020年2月2—16日采用网上问卷[含抑郁症筛查量表(PHQ-9)、焦虑症筛查量表(GAD-7)、患者健康问卷(PHQ-15)]的形式匿名调查于华中科技大学同济医学院附属同济医院隔离病房的106例COVID-19患者的心理健康状况。结果在106例COVID-19患者中,男性46例,女性60例,年龄(35.90±11.92)岁。在106例COVID-19患者中,抑郁情绪、焦虑情绪、躯体症状的检出率分别为49.06%(52/106)、56.60%(60/106)及69.81%(74/106),其中重度抑郁(PHQ-9评分>19分)、焦虑(GAD-7评分>14分)、躯体症状(PHQ-15评分>14分)患者的检出率分别为9.43%(10/106)、15.09%(16/106)、20.75%(22/106);67.92%(72/106)的COVID-19患者有睡眠问题;24.53%(26/106)的COVID-19患者有自残自杀观念;28.30%(30/106)的COVID-19患者有心理咨询需求。无焦虑或抑郁的患者仅占39.62%(42/106)。采用秩转换的非参数检验进行分析,结果显示已婚和核酸检测阳性的患者抑郁程度较重,已婚和需要吸氧的患者躯体症状严重程度较重。结论COVID-19患者存在明显的抑郁焦虑情绪及各种躯体症状,应早期识别、早期干预,避免出现极端事件如自残自杀观念等。尤其要特别关注已婚以及病情重的患者。 Objective To evaluate the status and influencing factors of the mental health of patients with COVID-19 during isolation treatment.Methods From February 2nd to 16th,2020,106 COVID-19 patients were anonymously investigated for their mental health status using online questionnaires(including Patient Health Questionnaire-9,Generalized Anxiety Disorder Scale-7,Patient Health Questionnaire-15 scales).The patients were from Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology.After data processing,SPSS19.0 was used for statistical analysis.Results Of the 106 COVID-19 patients,46 were male and 60 were female,with an age of(35.90±11.92)years.The detection rates of depression,anxiety and somatic symptoms in those patients were 49.06%(52/106),56.60%(60/106)and 69.81%(74/106)respectively.The severe cases of depression(scale score greater than 19),anxiety(scale score greater than 14)and somatic symptoms(scale score greater than 14)accounted for 9.43%(10/106),15.09%(16/106)and 20.75%(22/106)respectively.In addition,67.92%(72/106)of the patients had sleep problems,24.53%(26/106)had self-mutilating or suicidal thoughts,and 28.30%(30/106)required psychological counseling-all of which were at significantly higher percentages than those of the general population.Only 39.62%(42/106)of the examined patients had neither deression nor anxiety.By using the non-parametric test of rank conversion for analysis,the results showed that both married patients and nucleic-acid-positive patients had more severe depressions,and both married patients and anoxemic patients had more severe somatic symptoms.Conclusion This mental health assessment showed that depression,anxiety,and various somatic symptoms exist among the COVID-19 patients,and therefore early identification and intervention should be conducted to avoid extreme events such as self-mutilating or suicidal impulsivity,with a greater focus on both married patients and patients with severe symptoms.
作者 赵倩 胡彩虹 冯仁杰 杨渊 Zhao Qian;Hu Caihong;Feng Renjie;Yang Yuan(Department of Psychiatry,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Neurology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中华神经科杂志》 CAS CSCD 北大核心 2020年第6期432-436,共5页 Chinese Journal of Neurology
关键词 新型冠状病毒肺炎 抑郁 焦虑 躯体症状 COVID-19 Depression Anxiety Somatic symptoms
  • 相关文献

参考文献4

二级参考文献23

  • 1郝元涛,方积乾,Power M J,吴少敏,朱淑明.WHO生存质量评估简表的等价性评价[J].中国心理卫生杂志,2006,20(2):71-75. 被引量:285
  • 2Olfson M,Fireman B,Weissman MM,et al.Mental disorders and disability among patients in a primary care group practice.Am J Psychiatry,1997,154:1734-1740.
  • 3Roy-Byrne PP,Wagner A.Primary care perspectives on generalized anxiety disorder.J Clin Psychiatry,2004,65(suppl13):20-26.
  • 4Leon AC,Olfson M,Broadhead WE,et al.Prevalence of mental disorders in primary care:implications for screening.Arch Fam Med,1995,4:857-861.
  • 5Arikian SR,Gorman JM.A review of the diagnosis,pharmacologic treatment,and economic aspects of anxiety disorders.Primary Care Companion J Clin Psychiatry,2001,3:110-117.
  • 6Culpepper L.Use of algorithms to treat anxiety in primary care.J Clin Psychiatry,2003,64(suppl2):30-33.
  • 7L(o)we B,Unützer J,Callahan CM,et al.Monitoring depression treatment outcomes with the Patient Health Questionnaire-9.Med Care,2004,42:1194-1201.
  • 8Spitzer RL,Kroenke K,Williams JBW,et al.A brief measure for assessing generalized anxiety disorder:the GAD-7.Arch Intern Med,2006,166:1092-1097.
  • 9DeVellis RF.Scale development:theory and applications.Newbury Park:Sage Publications,1991:18-42.
  • 10L(o)we B,Decker O,Müller S,et al.Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.Medical Care,2008,46(3):266.

共引文献494

同被引文献205

引证文献17

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部